Myeloma tumor cells were defined by expression of the plasma cell marker CD138 (CD138+), while CD138-negative (CD138–) cells defined the myeloma cell microenvironment, which is composed of osteoblasts and osteoclasts, as well as stromal, endothelial, and immune cells. The gene discussed is SDC1; the disease is plasma cell myeloma.